RAC.AX Gross Margin

The Gross Margin of Race Oncology Ltd (RAC.AX) is -1165.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

RAC.AX Gross Margin - Historical Value

Date	Value
2025-06-30	-1165.00%
2024-06-30	-39.83%

RAC.AX Gross Margin - Peers Comparison

Ticker	Name	Value
CYP.AX	Cynata Therapeutics Ltd	85.71%
IMM.AX	Immutep Ltd	-933.05%
IVQ.AX	Invitrocue Ltd	47.13%
TLX.AX	Telix Pharmaceuticals Ltd	40.07%
ACW.AX	Actinogen Medical Ltd	7775.20%
BNO.AX	Bionomics Ltd	7775.20%
CDY.AX	Cellmid Ltd	6367.69%
KZA.AX	Kazia Therapeutics Ltd	77.60%
MDC.AX	Medlab Clinical Ltd	100.00%
TDL.AX	TBG Diagnostics Ltd	57.95%
ATH.AX	Alterity Therapeutics Ltd	19900.00%
CUV.AX	Clinuvel Pharmaceuticals Ltd	98.10%
HXL.AX	Hexima Ltd	89.29%
PYC.AX	PYC Therapeutics Ltd	-734868.00%
DXB.AX	Dimerix Ltd	60.00%
EX1.AX	Exopharm Ltd	4.52%
IMU.AX	Imugene Ltd	100.00%
LCT.AX	Living Cell Technologies Ltd	44.33%
NSB.AX	NeuroScientific Biopharmaceuticals Ltd	87.52%
OPT.AX	Opthea Ltd	-53.89%
PAB.AX	Patrys Ltd	100.00%
BIT.AX	Biotron Ltd	-120.34%
MSB.AX	Mesoblast Ltd	70.17%
VBS.AX	Vectus Biosystems Ltd	65.98%
ATX.AX	Amplia Therapeutics Ltd	92.42%
PAR.AX	Paradigm Biopharmaceuticals Ltd	99.71%
SCU.AX	Stemcell United Ltd	-2.79%